Your CDMO specialized in lentiviral vectors

Making the medicine of the future a reality

Our services

Experts in virology, we adapt ad-hoc to meet the specific requirements of your lentiviral vector.

Business model

GMP CDMO focused on different stages of the process.

Specialization

We work exclusively in lentivirus, offering comprehensive services.

Customized service

Technical adaptation and timely slot availability for each project.

Quality and safety

Compliance with EMA and FDA regulatory requirements.

Trusted by industry leaders

Vivebiotech in data

+20 customers

in the US, Europe and Asia

4x greater batch capacity

in reactor since 2020

3x increase in staff

since 2018

7 rooms dedicated

exclusively to lentivirus production

85% hold PhDs or bachelor's degrees

combining young talent and experience

About us

We are a Contract Development and Manufacturing Organization (CDMO) with over 20 biotech companies worldwide that have placed their trust in us.

Read more

Our value

VIVEbiotech is one of the only companies in the world specialized exclusively in lentiviral vectors. One of the things that sets us apart is our expertise not only in production but also virology, backed by a team of professionals with more than 30 years of experience.

Read more
See all news

Last news

26 November 2021

Gurutz Linazasoro has been awarded a 2021 Korta Award

The CEO of VIVEbiotech, Gurutz Linazasoro, has received one of the four 2021 Korta Awards delivered...

Read more

4 June 2021

VIVEbiotech launches lentiviral vector manufacturing plant for cell and gene therapy sector

VIVEbiotech’s production capacity will increase by 400%, with an increase in average batch size per...

Read more

With the support of